Vaibhav
☆    

India,
2022-06-23 23:31
(666 d 13:00 ago)

Posting: # 23077
Views: 1,456
 

 PK time points [Design Issues]

Dear All,
Are the below sampling points adequate for PK profile?
Median Tmax - 6 days
Mean half life: 26 days
Sub cutaneous: single dose
2, 12 and 24 hrs after administration. Additional samples were collected on day 2, 4, 6, 8, 10, 14, 28, 42, 56, 84, 112 and 140 days.
I have taken these time points from an article available in public domain.
Is there any method to calculate sampling point apart from method mentioned in BABE guidelines?
It’s a difficult to calculate time points for drug who has long Tmax and long half life.
Thank you in advance.


Edit: Category changed; see also this post #1[Helmut]
dshah
★★  

India/United Kingdom,
2022-06-24 13:29
(665 d 23:01 ago)

@ Vaibhav
Posting: # 23078
Views: 1,200
 

 PK time points

Dear Vaibhav!

❝ 2, 12 and 24 hrs after administration. Additional samples were collected on day 2, 4, 6, 8, 10, 14, 28, 42, 56, 84, 112 and 140 days.


I believe that addition of 6 hrs and 12 days would be helpful.
The method of administration would be also critical for impact on burst release.
What is your Cmax and LLOQ-ULOQ?
Regards,
Divyen Shah
UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,657 registered users;
91 visitors (0 registered, 91 guests [including 5 identified bots]).
Forum time: 12:31 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5